Kimberley Elting

Qualifications: JD, LL.M.

Date of Appointment: 2025

Kimberley Elting is a seasoned senior executive with more than 25 years of experience in the Medtech industry, with expertise in global commercialization, product development, public company governance, and legal matters. She has held senior executive positions at public and private companies and non-executive director and trustee positions on private and non-profit Boards. Kimberley most recently served as President of Global Orthopedics at Orthofix Medical Inc (Nasdaq OFIX) where she oversaw a global team in R&D, sales, marketing, manufacturing and G&A support functions developing, manufacturing and selling internal and external solutions for complex limb reconstruction and deformity correction. She originally joined Orthofix as Chief Legal Officer, assuming Regulatory, Quality, Chief Administrative and Business Development leadership roles prior to directing the global Orthopedics business. Before Orthofix, she served as General Counsel and Vice President of Corporate Affairs at TriVascular Technologies, Inc. (Nasdaq TriV) prior to and after its IPO and ultimate acquisition. In her early career she held various roles of increasing responsibility with St. Jude Medical (now Abbott) including General Counsel and Vice President of HR and Health Policy for the Neuromodulation Division. Kimberley previously was a partner at the Jones Day global law firm. A graduate of Ithaca College, Ms. Elting earned her Law Degree from the University of Denver and an LL.M. in Health Law from Loyola University Chicago.